These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 19163098

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Irreversible electroporation attenuates neointimal formation after angioplasty.
    Maor E, Ivorra A, Leor J, Rubinsky B.
    IEEE Trans Biomed Eng; 2008 Sep; 55(9):2268-74. PubMed ID: 18713696
    [Abstract] [Full Text] [Related]

  • 3. A preliminary study to delineate irreversible electroporation from thermal damage using the arrhenius equation.
    Shafiee H, Garcia PA, Davalos RV.
    J Biomech Eng; 2009 Jul; 131(7):074509. PubMed ID: 19640145
    [Abstract] [Full Text] [Related]

  • 4. Irreversible electroporation: a new ablation modality--clinical implications.
    Rubinsky B, Onik G, Mikus P.
    Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099
    [Abstract] [Full Text] [Related]

  • 5. A Study on Nonthermal Irreversible Electroporation of the Thyroid.
    Lv Y, Zhang Y, Huang J, Wang Y, Rubinsky B.
    Technol Cancer Res Treat; 2019 Jan 01; 18():1533033819876307. PubMed ID: 31564220
    [Abstract] [Full Text] [Related]

  • 6. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy.
    Davalos RV, Bhonsle S, Neal RE.
    Prostate; 2015 Jul 01; 75(10):1114-8. PubMed ID: 25809014
    [Abstract] [Full Text] [Related]

  • 7. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction.
    Arena CB, Sano MB, Rossmeisl JH, Caldwell JL, Garcia PA, Rylander MN, Davalos RV.
    Biomed Eng Online; 2011 Nov 21; 10():102. PubMed ID: 22104372
    [Abstract] [Full Text] [Related]

  • 8. Non thermal irreversible electroporation: novel technology for vascular smooth muscle cells ablation.
    Maor E, Ivorra A, Rubinsky B.
    PLoS One; 2009 Nov 21; 4(3):e4757. PubMed ID: 19270746
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endovascular nonthermal irreversible electroporation: a finite element analysis.
    Maor E, Rubinsky B.
    J Biomech Eng; 2010 Mar 21; 132(3):031008. PubMed ID: 20459196
    [Abstract] [Full Text] [Related]

  • 11. In vivo results of a new focal tissue ablation technique: irreversible electroporation.
    Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B.
    IEEE Trans Biomed Eng; 2006 Jul 21; 53(7):1409-15. PubMed ID: 16830945
    [Abstract] [Full Text] [Related]

  • 12. Development of a thermal model for irreversible electroporation: an approach to estimate and optimize the IRE protocols.
    Wardhana G, Almeida JP, Abayazid M, Fütterer JJ.
    Int J Comput Assist Radiol Surg; 2021 Aug 21; 16(8):1325-1334. PubMed ID: 34032965
    [Abstract] [Full Text] [Related]

  • 13. A statistical model for multidimensional irreversible electroporation cell death in tissue.
    Golberg A, Rubinsky B.
    Biomed Eng Online; 2010 Feb 26; 9():13. PubMed ID: 20187951
    [Abstract] [Full Text] [Related]

  • 14. Irreversible electroporation: just another form of thermal therapy?
    van Gemert MJ, Wagstaff PG, de Bruin DM, van Leeuwen TG, van der Wal AC, Heger M, van der Geld CW.
    Prostate; 2015 Feb 15; 75(3):332-5. PubMed ID: 25327875
    [Abstract] [Full Text] [Related]

  • 15. Tissue heterogeneity in structure and conductivity contribute to cell survival during irreversible electroporation ablation by "electric field sinks".
    Golberg A, Bruinsma BG, Uygun BE, Yarmush ML.
    Sci Rep; 2015 Feb 16; 5():8485. PubMed ID: 25684630
    [Abstract] [Full Text] [Related]

  • 16. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage.
    Neal RE, Smith RL, Kavnoudias H, Rosenfeldt F, Ou R, Mclean CA, Davalos RV, Thomson KR.
    Cardiovasc Intervent Radiol; 2013 Dec 16; 36(6):1638-1645. PubMed ID: 23942593
    [Abstract] [Full Text] [Related]

  • 17. MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model.
    Zhang Y, Guo Y, Ragin AB, Lewandowski RJ, Yang GY, Nijm GM, Sahakian AV, Omary RA, Larson AC.
    Radiology; 2010 Aug 16; 256(2):424-32. PubMed ID: 20656834
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
    Dunki-Jacobs EM, Philips P, Martin RC.
    Br J Surg; 2014 Aug 16; 101(9):1113-21. PubMed ID: 24961953
    [Abstract] [Full Text] [Related]

  • 19. Mathematical modeling of the thermal effects of irreversible electroporation for in vitro, in vivo, and clinical use: a systematic review.
    Agnass P, van Veldhuisen E, van Gemert MJC, van der Geld CWM, van Lienden KP, van Gulik TM, Meijerink MR, Besselink MG, Kok HP, Crezee J.
    Int J Hyperthermia; 2020 Aug 16; 37(1):486-505. PubMed ID: 32423258
    [Abstract] [Full Text] [Related]

  • 20. A parametric study delineating irreversible electroporation from thermal damage based on a minimally invasive intracranial procedure.
    Garcia PA, Rossmeisl JH, Neal RE, Ellis TL, Davalos RV.
    Biomed Eng Online; 2011 Apr 30; 10():34. PubMed ID: 21529373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.